We are live on ! Find out more
MC

Moors & Cabot Portfolio holdings

AUM $2.34B
1-Year Est. Return 30.42%
This Fund
S&P 500
This Quarter Est. Return
+7.9%
1 Year Est. Return
+30.42%
3 Year Est. Return
+101.7%
5 Year Est. Return
+135.96%
10 Year Est. Return
+427.28%
AUM
$1.43B
AUM Growth
+$120M
Cap. Flow
+$37.6M
Cap. Flow %
2.64%
Top 10 Hldgs %
21.85%
Holding
881
New
106
Increased
394
Reduced
245
Closed
44

Top Buys

Rank Stock Value
1
ALL icon
Allstate
ALL
+$5.59M
2
DGX icon
Quest Diagnostics
DGX
+$1.93M
3
Y
Alleghany Corp
Y
+$1.92M
4
CME icon
CME Group
CME
+$1.6M
5
TPL icon
Texas Pacific Land
TPL
+$1.55M

Top Sells

Rank Stock Value
1
WM icon
Waste Management
WM
+$8.55M
2
AMAT icon
Applied Materials
AMAT
+$1.45M
3
ADBE icon
Adobe
ADBE
+$1.3M
4
NVDA icon
NVIDIA
NVDA
+$950K
5
V icon
Visa
V
+$812K

Sector Composition

Rank Sector Weight
1 Technology 18.8%
2 Healthcare 12.07%
3 Financials 10.75%
4 Energy 9.22%
5 Industrials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHDG icon
676
Invesco S&P 500 Downside Hedged ETF
PHDG
$73.2M
$235K 0.02%
6,600
IFRA icon
677
iShares US Infrastructure ETF
IFRA
$4.62B
$234K 0.02%
+6,635
New +$238K
VHT icon
678
Vanguard Health Care ETF
VHT
$18.3B
$234K 0.02%
948
+66
+7% +$15.8K
BRO icon
679
Brown & Brown
BRO
$23.4B
$233K 0.02%
4,392
CACI icon
680
CACI
CACI
$10.9B
$232K 0.02%
+908
New +$234K
MKTX icon
681
MarketAxess Holdings
MKTX
$4.18B
$232K 0.02%
500
WYNN icon
682
Wynn Resorts
WYNN
$10.3B
$232K 0.02%
1,893
LEVI icon
683
Levi Strauss
LEVI
$9.71B
$230K 0.02%
8,301
-5,000
-38% -$137K
DRNA
684
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$227K 0.02%
+6,073
New +$186K
ARCC icon
685
Ares Capital
ARCC
$13.6B
$226K 0.02%
11,529
+717
+7% +$13.9K
TYL icon
686
Tyler Technologies
TYL
$12.8B
$226K 0.02%
499
-10
-2% -$4.25K
CERN
687
DELISTED
Cerner Corp
CERN
$225K 0.02%
2,877
+8
+0.3% +$615
EDIT icon
688
Editas Medicine
EDIT
$416M
$224K 0.02%
+3,951
New +$146K
IWR icon
689
iShares Russell Mid-Cap ETF
IWR
$56B
$224K 0.02%
+2,821
New +$219K
DNMR
690
DELISTED
Danimer Scientific, Inc.
DNMR
$224K 0.02%
224
-359
-62% -$358K
NUAN
691
DELISTED
Nuance Communications, Inc.
NUAN
$224K 0.02%
+4,110
New +$217K
EWT icon
692
iShares MSCI Taiwan ETF
EWT
$10B
$223K 0.02%
3,485
BRSL
693
Brightstar Lottery PLC
BRSL
$1.94B
$223K 0.02%
9,310
-1,490
-14% -$31.2K
BIP icon
694
Brookfield Infrastructure Partners
BIP
$18.8B
$222K 0.02%
+6,005
New +$217K
IVW icon
695
iShares S&P 500 Growth ETF
IVW
$72.5B
$222K 0.02%
+3,048
New +$211K
LMBS icon
696
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.35B
$222K 0.02%
+4,365
New +$223K
VPU
697
Vanguard Utilities ETF
VPU
$8.79B
$222K 0.02%
1,600
CTXS
698
DELISTED
Citrix Systems Inc
CTXS
$222K 0.02%
1,892
-70
-4% -$8.72K
EXC icon
699
Exelon
EXC
$48.6B
$221K 0.02%
6,981
+509
+8% +$16.4K
XMMO icon
700
Invesco S&P MidCap Momentum ETF
XMMO
$7.33B
$221K 0.02%
2,580

Similar funds

Moors & Cabot's Q2 2021 Portfolio in Review

As of Q2 2021, Moors & Cabot held 881 positions worth $1.43B, up 9.2% from $1.31B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Moors & Cabot's Q2 2021 filing shows 106 new, 394 increased, 245 reduced and 44 closed positions. Its largest new stake was Quest Diagnostics: 14,717 shares worth $1.94M. The largest sale was Waste Management, an estimated $8.55M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Moors & Cabot's largest Q2 2021 buy was Quest Diagnostics: 14,717 shares worth $1.94M.
  • Moors & Cabot added most to Allstate in Q2 2021, an estimated $5.59M increase.
  • Moors & Cabot's biggest Q2 2021 reduction was Waste Management, cutting an estimated $8.55M.
  • Moors & Cabot fully exited Mohawk Industries in Q2 2021, selling an estimated $583K.
  • Moors & Cabot's ten largest holdings make up 22% of its $1.43B portfolio in Q2 2021.
  • Moors & Cabot opened 106 new positions and closed 44 in Q2 2021.
  • Moors & Cabot's portfolio value rose 9.2% quarter-over-quarter to $1.43B.

Based on Moors & Cabot's 13F filing for Q2 2021, filed 10 Aug 2021.